Synthesis and antitumor activity of fused quinoline derivatives. II. Novel 4- and 7-hydroxyindolo-[3,2-b]quinolines

M. Yamato, Yasuo Takeuchi, M. Chang, K. Hashigaki

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Novel indolo[3,2-b]quinoline derivatives (1c-f), which carried a methoxy or a hydroxy group at the 4- or 7-position of the lead compound 1a, were prepared and their antitumor activities against P388 in mice were examined. Except for the 4-hydroxy derivative (1d), these showed remarkably potent activity. Among these compounds, the 7-hydroxy derivative (1f) was the most potent one (optimal dose = 50 mg/kg, the median survival time of treated group/control group (T/C) > 330%, cure = 5/6).

Original languageEnglish
Pages (from-to)528-530
Number of pages3
JournalChemical and Pharmaceutical Bulletin
Volume40
Issue number2
Publication statusPublished - 1992

Fingerprint

Quinolines
Derivatives
Control Groups
Lead compounds
quinoline
Lead

ASJC Scopus subject areas

  • Chemistry(all)
  • Organic Chemistry
  • Drug Discovery
  • Pharmacology

Cite this

Synthesis and antitumor activity of fused quinoline derivatives. II. Novel 4- and 7-hydroxyindolo-[3,2-b]quinolines. / Yamato, M.; Takeuchi, Yasuo; Chang, M.; Hashigaki, K.

In: Chemical and Pharmaceutical Bulletin, Vol. 40, No. 2, 1992, p. 528-530.

Research output: Contribution to journalArticle

@article{451dcdc806da44a09311c7fe0b1721ff,
title = "Synthesis and antitumor activity of fused quinoline derivatives. II. Novel 4- and 7-hydroxyindolo-[3,2-b]quinolines",
abstract = "Novel indolo[3,2-b]quinoline derivatives (1c-f), which carried a methoxy or a hydroxy group at the 4- or 7-position of the lead compound 1a, were prepared and their antitumor activities against P388 in mice were examined. Except for the 4-hydroxy derivative (1d), these showed remarkably potent activity. Among these compounds, the 7-hydroxy derivative (1f) was the most potent one (optimal dose = 50 mg/kg, the median survival time of treated group/control group (T/C) > 330{\%}, cure = 5/6).",
author = "M. Yamato and Yasuo Takeuchi and M. Chang and K. Hashigaki",
year = "1992",
language = "English",
volume = "40",
pages = "528--530",
journal = "Chemical and Pharmaceutical Bulletin",
issn = "0009-2363",
publisher = "Pharmaceutical Society of Japan",
number = "2",

}

TY - JOUR

T1 - Synthesis and antitumor activity of fused quinoline derivatives. II. Novel 4- and 7-hydroxyindolo-[3,2-b]quinolines

AU - Yamato, M.

AU - Takeuchi, Yasuo

AU - Chang, M.

AU - Hashigaki, K.

PY - 1992

Y1 - 1992

N2 - Novel indolo[3,2-b]quinoline derivatives (1c-f), which carried a methoxy or a hydroxy group at the 4- or 7-position of the lead compound 1a, were prepared and their antitumor activities against P388 in mice were examined. Except for the 4-hydroxy derivative (1d), these showed remarkably potent activity. Among these compounds, the 7-hydroxy derivative (1f) was the most potent one (optimal dose = 50 mg/kg, the median survival time of treated group/control group (T/C) > 330%, cure = 5/6).

AB - Novel indolo[3,2-b]quinoline derivatives (1c-f), which carried a methoxy or a hydroxy group at the 4- or 7-position of the lead compound 1a, were prepared and their antitumor activities against P388 in mice were examined. Except for the 4-hydroxy derivative (1d), these showed remarkably potent activity. Among these compounds, the 7-hydroxy derivative (1f) was the most potent one (optimal dose = 50 mg/kg, the median survival time of treated group/control group (T/C) > 330%, cure = 5/6).

UR - http://www.scopus.com/inward/record.url?scp=0026552164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026552164&partnerID=8YFLogxK

M3 - Article

C2 - 1606653

AN - SCOPUS:0026552164

VL - 40

SP - 528

EP - 530

JO - Chemical and Pharmaceutical Bulletin

JF - Chemical and Pharmaceutical Bulletin

SN - 0009-2363

IS - 2

ER -